Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Cell Immunol ; 331: 93-99, 2018 09.
Article in English | MEDLINE | ID: mdl-29895390

ABSTRACT

The engulfment of apoptotic cells by monocytes and unprimed macrophages results in M2 polarization. In the current study, we investigated whether apoptotic cells influence the phenotypic and functional characteristics of GM-CSF-differentiated human macrophages (GM-Mφ). Our results demonstrate that GM-Mφ preincubated with apoptotic neutrophils (GM-MφNeu) show significantly increased expression of CD206 and FasL and decreased capacity to stimulate allogeneic T-cell proliferation thus adopting M2 features. The 27-plex analysis demonstrates the down-regulation of 24 cytokines (including IL-10) in GM-MφNeu cultures. In contrast, apoptotic neutrophils enhance PGE2 synthesis by GM-Mφ, and blocking PGE2 production with indomethacin restores an allostimulatory activity of GM-MφNeu. These data provide evidence that GM-Mφ following exposure to apoptotic cells acquire features of M2 cells. Given the global suppression of cytokine secretion, GM-MφNeu resemble deactivated (M2c) macrophages, and their capacity to inhibit allogeneic T-cell proliferation appears to be mediated by an enhanced synthesis of PGE2 but not IL-10.


Subject(s)
Cell Differentiation/drug effects , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Macrophages/drug effects , Monocytes/drug effects , Adult , Apoptosis/drug effects , Cells, Cultured , Cytokines/metabolism , Dinoprostone/metabolism , Humans , Macrophages/cytology , Macrophages/metabolism , Monocytes/cytology , Monocytes/metabolism , Neutrophils/cytology , Neutrophils/drug effects , Neutrophils/metabolism , Young Adult
2.
Clin Dev Immunol ; 2012: 628635, 2012.
Article in English | MEDLINE | ID: mdl-23056139

ABSTRACT

The PD-1/B7-H1-mediated induction of T cell apoptosis/anergy as a possible mechanism of immune response failure was studied in 76 patients with pulmonary tuberculosis (TB) with normal and low-proliferative response to antigens of M. tuberculosis (purified protein derivative (PPD)). It was revealed that dendritic cells (DCs), generated in vitro from patient blood monocytes with GM-CSF + IFN-α, were characterized by increased B7-H1 expression, upproduction of IL-10, and reducing of allostimulatory activity in mixed lymphocyte culture (MLC). Moreover, DCs of patients with TB were able to enhance T cell apoptosis and to block T-cell division in MLC. It was shown that neutralizing anti-PD1 antibodies significantly decreased the proapoptogenic/tolerogenic effect of DCs. Correlation analysis revealed a direct relationship between IL-10 production and level of B7-H1 expression in the general group of investigated patients. It was demonstrated that generation of healthy donor DCs in the presence of IL-10 led to an increase in the number of DCs-expressed B7-H1 molecule, DC proapoptogenic activity, and a decrease in their allostimulatory activity. Obviously, the revealed phenomenon of the PD-1/B7-H1-mediated pro-apoptogenic activity of DCs is clinically significant since the cytotoxic/tolerogenic potential of DCs is more pronounced in patients with PPD anergy.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Dendritic Cells/immunology , Immunotherapy, Adoptive/methods , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/therapy , Adolescent , Adult , Antibodies, Neutralizing/immunology , Antigens, Bacterial/immunology , Apoptosis/immunology , Apoptosis Regulatory Proteins/immunology , B7-H1 Antigen/immunology , Cytotoxicity, Immunologic , Dendritic Cells/drug effects , Female , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Humans , Interferon-gamma/immunology , Interferon-gamma/pharmacology , Interleukin-10/immunology , Male , Middle Aged , Monocytes/drug effects , Monocytes/immunology , Mycobacterium tuberculosis/immunology , Programmed Cell Death 1 Receptor/immunology , Young Adult
3.
Cell Immunol ; 262(2): 120-6, 2010.
Article in English | MEDLINE | ID: mdl-20170907

ABSTRACT

Exogenous allogenic DNA as nucleosome-free fragments reaches main cellular compartments (cytoplasm, nucleus) of human dendritic cells and deposits in the nuclear interchromosomal space without visibly changing in linear size. The presence of such allogenic fragmented DNA in medium in which human dendritic cells are cultured produces an enhancement of their allostimulatory activity. This enhancement is comparable to that produced by the standard maturation stimulus lipopolysaccharide Escherichia coli.


Subject(s)
DNA/immunology , Dendritic Cells/immunology , Endocytosis/immunology , Animals , DNA/ultrastructure , Dendritic Cells/cytology , HeLa Cells , Humans , Mice
4.
Cell Immunol ; 266(1): 46-51, 2010.
Article in English | MEDLINE | ID: mdl-20863487

ABSTRACT

A preparation of human genomic fragmented double-stranded DNA (dsDNA) was used as maturation stimulus in cultures of human dendritic cells (DCs) generated in compliance with the interferon protocol. Culturing of the DCs in medium with 5µg/ml of the DNA preparation was associated with a decrease in the relative proportion of CD14 + cells and an increase in that of CD83 + cells. These changes are markers of DC maturation. The efficiency with which the DNA preparation was able to elicit DC maturation was commensurate with that of lypopolysaccharide from bacterial cell, the standard inducer of DC maturation. Generated ex vivo, matured in the presence of the human DNA preparation, pulsed with tumor antigens mouse DCs were used as a vaccine in biological tests for its antitumor activity. The experimental results demonstrate that reinfusion of mature pulsed with tumor antigens DCs cause a statistically significant suppression of tumor graft growth.


Subject(s)
Cell Differentiation/drug effects , DNA/pharmacology , Dendritic Cells/cytology , Dendritic Cells/immunology , Animals , Antigens, CD/metabolism , Antigens, Neoplasm/immunology , Cancer Vaccines/immunology , Cancer Vaccines/therapeutic use , Carcinoma, Ehrlich Tumor/immunology , Carcinoma, Ehrlich Tumor/prevention & control , Dendritic Cells/drug effects , Dendritic Cells/metabolism , Female , Humans , Immunoglobulins/metabolism , Interleukin-2 Receptor alpha Subunit/metabolism , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/metabolism , Lipopolysaccharide Receptors/metabolism , Lipopolysaccharides/pharmacology , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred CBA , Tumor Necrosis Factor-alpha/pharmacology , Xenograft Model Antitumor Assays , CD83 Antigen
5.
J Pharm Pharmacol ; 68(12): 1516-1526, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27704584

ABSTRACT

OBJECTIVES: We evaluated the hypolipidaemic effect of mannan Candida albicans serotype A, relative to atorvastatin, in a mouse model of hyperlipidaemia. METHODS: Mannan serotype A was investigated in vitro and in vivo to determine its effects on macrophage proliferation, nitric oxide (NO) production by cultured macrophages, serum and liver lipids, changes in liver morphology and serum chitotriosidase activity and its expression in the liver. KEY FINDINGS: Mannan serotype A stimulates the macrophage proliferation and NO production in murine peritoneal macrophages in vitro. The activity of serum chitotriosidase (an enzyme released from the activated macrophages) was found to be significantly increased in P-407-induced hyperlipidaemic mice pretreated with low-dose mannan compared with mice administered P-407 only. Mannan treatment in mice was shown to significantly increase the chitotriosidase expression in the liver of both non-hyperlipidaemic and P-407-induced hyperlipidaemic mice. Lastly, mice pretreated with mannan before the induction of hyperlipidaemia with P-407 showed a significant reduction in the serum concentration of atherogenic LDL cholesterol, total cholesterol, triglycerides and liver triglycerides. CONCLUSIONS: It is suggested that mannan serotype A, like ß-glucan, may represent another hypolipidaemic agent, which could potentially be used as an adjunctive therapy with conventional antihyperlipidaemic drugs (statins and fibrates) in humans.


Subject(s)
Atorvastatin/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hyperlipidemias/drug therapy , Lipids/blood , Liver/drug effects , Mannans/pharmacology , Poloxamer , Animals , Biomarkers/blood , Cell Proliferation/drug effects , Cells, Cultured , Disease Models, Animal , Down-Regulation , Hexosaminidases/metabolism , Hyperlipidemias/blood , Hyperlipidemias/chemically induced , Hyperlipidemias/pathology , Lipid Droplets/drug effects , Lipid Droplets/metabolism , Lipid Droplets/ultrastructure , Liver/metabolism , Liver/ultrastructure , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Macrophages, Peritoneal/pathology , Male , Mice, Inbred CBA , Microscopy, Electron , Nitric Oxide/metabolism
6.
J Immunol Res ; 2015: 793292, 2015.
Article in English | MEDLINE | ID: mdl-26339660

ABSTRACT

The phenotype and functional properties of antigen-presenting cells (APC), that is, circulating monocytes and generated in vitro macrophages and dendritic cells, were investigated in the patients with pulmonary tuberculosis (TB) differing in lymphocyte reactivity to M. tuberculosis antigens (PPD-reactive versus PPD-anergic patients). We revealed the distinct impairments in patient APC functions. For example, the monocyte dysfunctions were displayed by low CD86 and HLA-DR expression, 2-fold increase in CD14(+)CD16(+) expression, the high numbers of IL-10-producing cells, and enhanced IL-10 and IL-6 production upon LPS-stimulation. The macrophages which were in vitro generated from peripheral blood monocytes under GM-CSF were characterized by Th1/Th2-balance shifting (downproduction of IFN-γ coupled with upproduction of IL-10) and by reducing of allostimulatory activity in mixed lymphocyte culture. The dendritic cells (generated in vitro from peripheral blood monocytes upon GM-CSF + IFN-α) were characterized by impaired maturation/activation, a lower level of IFN-γ production in conjunction with an enhanced capacity to produce IL-10 and IL-6, and a profound reduction of allostimulatory activity. The APC dysfunctions were found to be most prominent in PPD-anergic patients. The possible role of APC impairments in reducing the antigen-specific T-cell response to M. tuberculosis was discussed.


Subject(s)
Antigen-Presenting Cells/immunology , Mycobacterium tuberculosis/immunology , Tuberculosis, Pulmonary/immunology , Adult , Antigen-Presenting Cells/metabolism , Biomarkers , Cytokines/metabolism , Dendritic Cells/immunology , Dendritic Cells/metabolism , Female , Humans , Immunophenotyping , Lymphocyte Activation/immunology , Macrophages/immunology , Macrophages/metabolism , Male , Middle Aged , Monocytes/immunology , Monocytes/metabolism , Mycobacterium tuberculosis/metabolism , Phenotype , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Tuberculosis, Pulmonary/metabolism , Young Adult
7.
J Cell Mol Med ; 11(3): 531-51, 2007.
Article in English | MEDLINE | ID: mdl-17635644

ABSTRACT

It was shown that IgGs from the sera of 2-7-month-old control non-autoimmune (CBA x C57BL)F1 and BALB/c mice and 2-3-month-old autoimmune prone MRL-lpr/lpr mice (conditionally healthy mice) are catalytically inactive. During spontaneous development of deep systemic lupus erythematosus (SLE)-like pathology a specific reorganization of immune system of these mice leads to conditions associated with a production of IgGs hydrolyzing DNA, ATP and polysaccharides with low catalytic activities (conditionally pre-diseased mice).A significant increase in DNase, ATPase and amylase IgG relative activities associated with a transition from pre-diseased to deep diseased mice is correlated with additional changes in differentiation and proliferation of mice bone marrow haematopoietic stem cells (HSCs) and lymphocyte proliferation in different organs. The highest increase in all abzyme activities was found in mice immunized with DNA, which in comparison with pre-diseased and diseased mice are characterized by a different profile of HSC differentiation and by a suppression of cell apoptosis. Abzyme activities in the serum of pregnant females were comparable with those for pre-diseased mice, but the profile of HSC differentiation and cell apoptosis levels in pregnant and pre-diseased mice were quite different. Right after the beginning of lactation (4 days after delivery) and in a late time of lactation (14 days after delivery) there was an observed increase in cell apoptosis and two different stages of significant change in the HSC differentiation profiles; the first stage was accompanied with a significant increase and the second with a remarkable decrease in abzyme activities. Overall, all mouse groups investigated are characterized by a specific relationship between abzyme activities, HSC differentiation profiles, levels of lymphocyte proliferation, and cell apoptosis in different organs. From our point of view, the appearance of ATPase, DNase activities may be considered the earliest statistically significant marker of mouse spontaneous SLE and a further significant increase in their activities correlates with the appearance of SLE visible markers and with an increase in concentrations of anti-DNA Abs and urine protein. However, development of autoimmune (AI)-reactions and the increase in the sera anti-DNA antibodies (Abs) and in the abzyme activities in pregnant and lactating mice do not associate with SLE visible markers and proteinuria. The possible differences in immune system reorganizations during pre-disease, disease, pregnancy and lactation leading to production of different auto-antibodies and abzymes are discussed.


Subject(s)
Antibodies, Catalytic/immunology , Autoimmune Diseases/immunology , Colony-Forming Units Assay , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/immunology , Adenosine Triphosphatases/metabolism , Amylases/metabolism , Animals , Apoptosis , Cattle , Cell Proliferation , Deoxyribonucleases/metabolism , Female , Hematopoietic Stem Cells/enzymology , Immunoglobulin G/isolation & purification , Lactation , Lymphocytes/cytology , Mice , Mice, Inbred MRL lpr , Organ Specificity , Pregnancy
8.
Russ J Immunol ; 7(3): 245-50, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12674934

ABSTRACT

Lymphocyte proliferation and apoptosis at different stages of the development of the autoimmune disorder in MRL/MpJ-lpr mice was studied. Hematopoietic progenitor colony formation during the course of the disease was characterized. A detectable difference at the level of lymphocyte proliferation, apoptosis, and the relative amount of BFU-E, CFU-GM and CFU-GEMM cell colonies was revealed between healthy young mice and animals spontaneously developing pronounced symptoms of the autoimmune disorder. The quantity of BFU-E and CFU-GEMM colonies was remarkably increases in aged MRL/MpJ-lpr mice even before clinical manifestation of the disease (proteinuria). An elevated number of CFU-GEMM was accompanied by a striking increase in their size. The study of hematopoietic disturbances in autoimmune MRL/MpJ-lpr mice may be very useful for understanding the mechanism of the autoimmune disease development and searching for new strategies of the correction of the autoimmune disorder.


Subject(s)
Autoimmune Diseases/etiology , Autoimmune Diseases/immunology , Hematopoietic Stem Cells/immunology , Animals , Apoptosis/immunology , Autoimmune Diseases/pathology , Cell Division/immunology , Cell Line , Hematopoietic Stem Cells/pathology , In Vitro Techniques , Lymph Nodes/immunology , Lymphocytes/immunology , Mice , Mice, Inbred MRL lpr , Proteinuria/genetics , Proteinuria/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL